William Blair & Company
CRDF icon

William Blair & Company’s Cardiff Oncology CRDF Stock Holding History

William Blair & Company’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
912,513
-9,894
-1% -$15.7K ﹤0.01% 919
2026
Q1 		$1.49M Sell
922,407
-1,026,440
-53% -$2.11M ﹤0.01% 825
2025
Q4 		$5.48M Sell
1,948,847
-264,759
-12% -$615K 0.01% 490
2025
Q3 		$4.56M Sell
2,213,606
-310,512
-12% -$858K 0.01% 538
2025
Q2 		$7.95M Buy
2,524,118
+772,844
+44% +$2.36M 0.02% 398
2025
Q1 		$5.5M Buy
1,751,274
+1,469,249
+521% +$5.81M 0.02% 461
2024
Q4 		$1.22M Buy
282,025
+34,947
+14% +$109K ﹤0.01% 831
2024
Q3 		$660K Buy
247,078
+19,448
+9% +$45.9K ﹤0.01% 1039
2024
Q2 		$505K Buy
227,630
+55,450
+32% +$209K ﹤0.01% 1096
2024
Q1 		$919K Buy
172,180
+42,180
+32% +$112K ﹤0.01% 897
2023
Q4 		$192K Sell
130,000
-500
-0.4% -$605 ﹤0.01% 1410
2023
Q3 		$181K Hold
130,500
– – ﹤0.01% 1408
2023
Q2 		$192K Hold
130,500
– – ﹤0.01% 1416
2023
Q1 		$215K Sell
130,500
-21,075
-14% -$36.2K ﹤0.01% 1377
2022
Q4 		$212K Sell
151,575
-18,000
-11% -$25.8K ﹤0.01% 1349
2022
Q3 		$261K Buy
169,575
+37,000
+28% +$89K ﹤0.01% 1283
2022
Q2 		$292K Buy
132,575
+42,700
+48% +$71.5K ﹤0.01% 1283
2022
Q1 		$223K Sell
89,875
-117,615
-57% -$416K ﹤0.01% 1479
2021
Q4 		$1.25M Sell
207,490
-3,270
-2% -$19.5K ﹤0.01% 886
2021
Q3 		$1.4M Buy
+210,760
New +$1.32M ﹤0.01% 798

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

William Blair & Company's CRDF Position: Q2 2026 in Review

William Blair & Company reduced its Cardiff Oncology (CRDF) stake by 1.1% in Q2 2026, selling an estimated $15.7K and leaving 912,513 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #919.

William Blair & Company first reported a position in CRDF in Q3 2021 and has held it in 20 quarters since. The position peaked at $7.95M in Q2 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • William Blair & Company held 912,513 shares of Cardiff Oncology worth $1.19M as of Q2 2026.
  • William Blair & Company sold 9,894 Cardiff Oncology shares in Q2 2026, an estimated $15.7K.
  • Cardiff Oncology made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #919 holding.
  • William Blair & Company first reported a position in Cardiff Oncology in Q3 2021 and has held it in 20 quarters since.
  • William Blair & Company's Cardiff Oncology position peaked at $7.95M in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.